A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Advanced Breast Cancer
Related studies linked through entity extraction aliases.
Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA)
- Status
- COMPLETED
- Phase
- N/A
A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)
- Status
- COMPLETED
- Phase
- PHASE2
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Hypo-Fractionated Radiotherapy in Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Southeast Netherlands Advanced Metastatic Breast Cancer Registry
- Status
- RECRUITING
- Phase
- N/A
Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Plasmodium Immunotherapy for Breast and Liver Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
Patterns of Prescribing and Monitoring of Palbociclib
- Status
- COMPLETED
- Phase
- N/A
Clinical Study of Decitabine and Paclitaxel Combination Therapy
- Status
- UNKNOWN
- Phase
- PHASE1
Palbociclib in Real World Practice
- Status
- COMPLETED
- Phase
- N/A
Halaven Patient Registry (Metastatic Breast Cancer, MBC)
- Status
- UNKNOWN
- Phase
- N/A
Bioinformation Therapy for Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2